Glucosamine in osteoarthritis (multiple letters) [1]

Lancet

Volumn 354, Issue 9190, 1999, Pages 1640-1642

  Rovati, L C ^a   Annefeld, M ^a   Giacovelli, G ^a   Schmid, K ^a   Setnikar, I ^a  

^a Rotta Research Laboratorium   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSAMINE;

LETTER; OSTEOARTHRITIS; PRIORITY JOURNAL; ANIMAL; DOG; GLUCOSE BLOOD LEVEL; HUMAN; METABOLISM; NOTE;

ANIMALS; BLOOD GLUCOSE; DOGS; GLUCOSAMINE; HUMANS; OSTEOARTHRITIS;

EID: 0033530436     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)90195-2     Document Type: Letter

References (5)

1. ME Adams Hype about glucosamine Lancet 354 1999 353 354
2. R Altman K Brandt M Hochberg R Moskowitz Design and conduct of clinical trials of patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society Osteoarthritis Cart 4 1996 217 243
3. W Noack M Fischer KK Förster LC Rovati I Setnikar Glucosamine sulfate in osteoarthritis of the knee Osteoarthritis Cart 2 1994 51 59
4. I Setnikar C Giachetti G Zanolo Pharmacokinetics of glucosamine in the dog and in man Arzneim Forsch 36 1986 729 735
5. Reginster JY, Deroisy R, Paul I, et al. Glucosamine sulfate significantly reduces progression of knee osteoarthritis over 3 years: a large, randomised, placebo controlled, double-blind, prospective trial. Osteoarthritis Cart (in press) (abstr).